How is high-risk HPV positivity treated?
In daily life, many individuals discover—during routine health checkups—that their test reports indicate a high-risk HPV (human papillomavirus) positive result, causing significant concern. This often leads to seeking unguided or inappropriate medical care, ultimately failing to improve or resolve the condition. In fact, for any health issue, patients should consult tertiary hospitals (Level 3A or above) to receive professional, evidence-based treatment. So, how is high-risk HPV infection treated? Below, we address this question.

How Is High-Risk HPV Infection Treated?
1. Symptomatic Pharmacotherapy
If viral load is low, treatment may include vaginal effervescent tablets (e.g., compound effervescent tablets) or interferon suppositories, which help suppress further viral damage to the body. Oral antiviral agents such as Ribavirin (Rebeisheng) may also be prescribed for adjunctive therapeutic effect. Additionally, if subsequent tests yield negative results, antiviral therapy remains essential to prevent reinfection and disease progression. Close clinical monitoring is required. Patients should maintain good sexual hygiene, undergo antiviral therapy to prevent genital tract infections, and cultivate a positive mindset while engaging in regular physical exercise.

2. General Management
High-risk HPV is transmissible; therefore, sexual intercourse should be avoided during active infection. Personal hygiene items—including clothing, towels, and toilet seats—must be kept separate from those used by others to prevent transmission. As high-risk HPV infection represents a precancerous condition, prompt and proactive treatment is crucial to prevent progression to cervical cancer. Procedures such as Loop Electrosurgical Excision Procedure (LEEP) may be employed, and regular follow-up examinations are mandatory to monitor disease progression. Moreover, patients with high-risk HPV infection should undergo additional ThinPrep Cytologic Test (TCT) screening—ideally scheduled outside of menstruation.

3. Regular Screening
Regular screening is essential to detect precancerous lesions early and initiate timely intervention. Systemic treatments—including intravenous antiviral agents and immunomodulators to enhance host immunity—may be administered. Locally, interferon suppositories or gels can be applied vaginally, or interferon may be administered via injection. Strengthening the immune system facilitates viral clearance. Patients should maintain regular作息 (sleep-wake cycles), engage in appropriate physical activity, improve overall physical fitness, and bolster natural immunity. Furthermore, individuals with persistent HPV positivity require periodic TCT screening.
The above outlines current approaches to managing high-risk HPV infection. We hope this information proves helpful to you.